Related Experiment Videos

Treatment of meconium aspiration syndrome with surfactant lavage in an experimental rabbit model

Y Ohama1, Y Ogawa

  • 1Department of Pediatrics, Saitama Medical Center, Saitama Medical School, Japan.

Pediatric Pulmonology
|July 16, 1999
PubMed

Insights

Surfactant lavage effectively treats meconium aspiration syndrome (MAS) in rabbits. A 10 mg/mL surfactant concentration improved gas exchange and lung histology, outperforming saline lavage.

Area of Science:

  • Neonatal Medicine
  • Respiratory Physiology
  • Pulmonary Pathology

Background:

  • Meconium aspiration syndrome (MAS) frequently causes respiratory distress in newborns.
  • Surfactant dysfunction is implicated in MAS pathophysiology.
  • Novel therapeutic strategies for MAS are needed.

Purpose of the Study:

  • To evaluate the efficacy of different surfactant concentrations in meconium lavage fluid.
  • To assess the impact of surfactant lavage on gas exchange and lung histology in a rabbit MAS model.

Main Methods:

  • Rabbits received endotracheal meconium instillation and mechanical ventilation.
  • Animals underwent lavage with saline or surfactant suspensions (2.5, 5, or 10 mg/mL).
  • Meconium recovery, gas exchange, and lung histology were analyzed.

Main Results:

  • The 10 mg/mL surfactant lavage group showed significant improvement in gas exchange.
  • Higher meconium recovery was observed in the 10 mg/mL surfactant group.
  • Surfactant lavage reduced alveolar inflammation compared to saline lavage.

Conclusions:

  • Lavage with 10 mg/mL surfactant solution is most effective for meconium clearance.
  • Surfactant lavage improves gas exchange and lung histology in a rabbit MAS model.
  • This approach offers a promising therapeutic option for meconium aspiration syndrome.

Related Concept Videos